Previous 10 | Next 10 |
TEL AVIV , Israel and BETHESDA, Maryland , April 27, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has appointed Prof. Zamir Halpern to i...
TEL AVIV , Israel and BETHESDA, Maryland , April 13, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has completed its preclinical development o...
TEL AVIV , Israel and BETHESDA, Maryland , March 25, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that its R&D team in Israel studies the combi...
TEL AVIV , Israel and BETHESDA, Maryland , March 18, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it is offering its High Throughput Screening (HTS)...
TEL AVIV, Israel and BETHESDA, Maryland , March 11, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has completed a scan of selected RCKMC's cannabis strains....
Cannabics Pharmaceuticals ( OTCQB:CNBX ) signs a new agreement with NewCanna Hub to research the anti-tumor effects of cannabinoid profiles found in indigenous Colombian landraces. More news on: Cannabics Pharmaceuticals Inc., Healthcare stocks news, Read more ...
TEL AVIV, Israel and BETHESDA, Maryland , Feb. 25, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed an agreement with NewCanna Hub, a company locate...
TEL AVIV, Israel and BETHESDA, Maryland , Feb. 18, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that the cannabinoids CBN (Cannabinol) and CBC (Cannabichromene) an...
TEL AVIV , Israel and BETHESDA, Maryland, Feb. 11, 2020 /PRNewswire/ -- Cannabics Pharmaceuticals Inc. (OTCQB: CNBX), a leader in personalized cannabinoid medicine focused on cancer and its side effects, announced today that it has signed a Memorandum Of Underst...
5 Penny Stocks To Watch Before Friday This week we’ve seen a crazy mix of health concerns and economic uncertainty push the market all over the place. However, following the initial drop, the market has started to recover. Lack of volatility can make investors look for places where ther...
News, Short Squeeze, Breakout and More Instantly...
Cannabics Pharmaceuticals Inc Company Name:
CNBX Stock Symbol:
OTCMKTS Market:
Cannabics Pharmaceuticals Inc Website:
CNBX Pharmaceuticals Inc (CNBX) is expected to report for Q1 2003
CNBX to Enter the Cancer Immunotherapy Market After Acquiring a Controlling Interest in TaGeza Biopharma PR Newswire REHOVOT, Israel and BETHESDA, MD , Nov. 8, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader i...
CNBX Files New PCT Patent Application For Cannabinoids-Based Neoadjuvant Cancer Therapy PR Newswire REHOVOT, Israel and BETHESDA, MD. , Oct. 18, 2022 /PRNewswire/ -- CNBX Pharmaceuticals Inc. (OTCQB: CNBX), a global leader in the development of...